Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Cell Tissue Res ; 328(3): 473-86, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17318587

ABSTRACT

The formation of peripheral lymphoid tissues is indispensable for the efficient recognition and elimination of external antigens by lymphoid and accessory cells of the adaptive immune system. The spleen is structurally arranged around various vascular beds with distinct endothelial phenotypes. Using immunohistochemistry, we investigated the postnatal developmental characteristics of the marginal sinus and its relationship with various red-pulp sinus subsets. We also determined the importance of the lymphotoxin beta receptor (LT beta R) and the role of the Nkx2.3 transcription factor for the formation of the splenic vasculature. Both the administration of soluble LT beta R-Ig fusion protein to neonates and the deletion of LT beta R or downstream signaling components (RelB and p52) of the NF-kappaB family inhibited the phenotypic maturation of marginal sinus but had no effect on the vascular compartmentalization of the red pulp. The integrity of the marginal sinus and the proper vascular segregation of the red pulp appeared to be controlled by Nkx2.3, as Nkx2.3-deficient mice exhibited an abnormal distribution of IBL-7/1(hi)/IBL-9/2(-) sinuses and a lack of IBL-7/1(lo)/IBL-9/2(+) vessels. Our data suggest that phenotypic heterogeneity among different vascular elements within distinct anatomical regions of the spleen differentially depends on developmental factors such as lymphotoxin signaling or Nkx2.3, whereas the marginal sinus is controlled by both pathways.


Subject(s)
Endothelium, Vascular/cytology , Homeodomain Proteins/physiology , Lymphotoxin-beta/physiology , Spleen/blood supply , Transcription Factors/physiology , Animals , Animals, Newborn , Cell Adhesion Molecules/metabolism , Cell Differentiation/genetics , Endothelium, Vascular/metabolism , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Lymphotoxin beta Receptor/genetics , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Mice, Knockout , Mice, SCID , Models, Biological , Mucoproteins , Signal Transduction/physiology , Spleen/cytology , Spleen/metabolism , Transcription Factors/genetics
2.
EMBO J ; 22(1): 121-30, 2003 Jan 02.
Article in English | MEDLINE | ID: mdl-12505990

ABSTRACT

Targeted disruption of the Rel/NF-kappaB family members NF-kappaB2, encoding p100/p52, and RelB in mice results in anatomical defects of secondary lymphoid tissues. Here, we report that development of Peyer's patch (PP)-organizing centers is impaired in both NF-kappaB2- and RelB-deficient animals. IL-7-induced expression of lymphotoxin (LT) in intestinal cells, a crucial step in PP development, is not impaired in RelB-deficient embryos. LTbeta receptor (LTbetaR)-deficient mice also lack PPs, and we demonstrate that LTbetaR signaling induces p52-RelB and classical p50-RelA heterodimers, while tumor necrosis factor (TNF) activates only RelA. LTbetaR-induced binding of p52-RelB requires the degradation of the inhibitory p52 precursor, p100, which is mediated by the NF-kappaB-inducing kinase (NIK) and the IkappaB kinase (IKK) complex subunit IKKalpha, but not IKKbeta or IKKgamma. Activation of RelA requires all three IKK subunits, but is independent of NIK. Finally, we show that TNF increases p100 levels, resulting in the specific inhibition of RelB DNA binding via the C-terminus of p100. Our data indicate an important role of p52-RelB heterodimers in lymphoid organ development downstream of LTbetaR, NIK and IKKalpha.


Subject(s)
Lymphotoxin-alpha/pharmacology , Peyer's Patches/cytology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Trans-Activators/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Adaptor Proteins, Signal Transducing , Animals , Cells, Cultured , DNA Primers , Gene Expression Regulation/drug effects , Intestinal Mucosa/embryology , Mice , Mice, Knockout , NF-kappa B/antagonists & inhibitors , NF-kappa B/deficiency , NF-kappa B/genetics , NF-kappa B p52 Subunit , Proto-Oncogene Proteins/deficiency , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Trans-Activators/genetics , Transcription Factor RelB , Transcription Factors/deficiency , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL